Try it
Microbiology · Mycology: mucormycosis and iron
Sample itemA patient on maintenance dialysis is treated with deferoxamine for iron overload and develops rhino-orbital mucormycosis. What explains the increased risk?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
B. Mucorales use the iron-deferoxamine complex as a siderophore to obtain iron for growth
Free iron is normally tightly bound, which limits fungal growth. Mucorales can take up iron from ferrioxamine, so deferoxamine chelation actually feeds the fungus. Treatment of mucormycosis is liposomal amphotericin B with urgent surgical debridement and correction of the underlying risk.
Option by option
A. Deferoxamine suppresses neutrophil chemotaxis directly
Impaired neutrophil function is not the mechanism linking deferoxamine to mucormycosis.
B. Mucorales use the iron-deferoxamine complex as a siderophore to obtain iron for growth (correct)
Correct. The fungus uses ferrioxamine as an iron source.
C. Deferoxamine causes ketoacidosis similar to uncontrolled diabetes
Deferoxamine does not cause ketoacidosis, though acidosis from diabetes also impairs phagocytes.
D. Deferoxamine damages the nasal mucosa and removes the epithelial barrier
Deferoxamine has no direct toxic effect on mucosal barriers.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Microbiology questions
- BacteriologyA patient has profuse painless watery 'rice-water' stools and rapid dehydration. The cau…
- Culture mediaThayer–Martin medium is used selectively to isolate which organism?
- Immunology and serologyWhich of the following is a non-treponemal test for syphilis?
- BacteriologyAlbert's stain is used to demonstrate which of the following?